ARCHIVES

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

This article is from The Cancer Letter archive.

Vol. 34 No. 08 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

In Brief: David Harrington Replaces Zelen At ECOG; Kushnet To Receive Ewing Layman’s Award

December 1, 1989

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

Investigators Plan To Interview DeVita, Mendelsohn on C225 Development

July 5, 2002